Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4291378
Max Phase: Preclinical
Molecular Formula: C19H18NO3P
Molecular Weight: 339.33
Molecule Type: Small molecule
Associated Items:
ID: ALA4291378
Max Phase: Preclinical
Molecular Formula: C19H18NO3P
Molecular Weight: 339.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=P(O)(O)C(Nc1cccc(-c2ccccc2)c1)c1ccccc1
Standard InChI: InChI=1S/C19H18NO3P/c21-24(22,23)19(16-10-5-2-6-11-16)20-18-13-7-12-17(14-18)15-8-3-1-4-9-15/h1-14,19-20H,(H2,21,22,23)
Standard InChI Key: OAICHXGQZLTXBH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 339.33 | Molecular Weight (Monoisotopic): 339.1024 | AlogP: 4.64 | #Rotatable Bonds: 5 |
Polar Surface Area: 69.56 | Molecular Species: ACID | HBA: 2 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.42 | CX Basic pKa: | CX LogP: 3.86 | CX LogD: 1.47 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.59 | Np Likeness Score: -0.59 |
1. Chen Z, Marcé P, Resende R, Alzari PM, Frasch AC, van den Elsen JMH, Crennell SJ, Watts AG.. (2018) The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase., 158 [PMID:30199703] [10.1016/j.ejmech.2018.08.089] |
Source(1):